Retrieve available abstracts of 66 articles: HTML format
Single Articles
July 2025
BOWDEN SJ, Bodinier B, Paraskevaidi M, Kalliala I, et al DNA methylation signatures of cervical pre-invasive and invasive disease: An
epigenome-wide association study.
Int J Cancer. 2025;157:305-316. PubMedAbstract available
BJORGE T, Stoer NC, Hverven SK, Nygard M, et al Risk of high-grade cervical lesions in the second round of primary human
papillomavirus testing in CervicalScreen Norway: A population-based cohort study.
Int J Cancer. 2025;157:251-259. PubMedAbstract available
CHANDRAN A, Mackie A, Sasieni P, Arbyn M, et al Technical, legal and ethical framework of cancer audit in cervical screening -
Summary of best practices for organised programmes delineated through an expert
group consultation.
Int J Cancer. 2025;157:32-40. PubMedAbstract available
June 2025
ZHENG Y, Han J, Qu Y, Wang J, et al DNA methylation biomarkers for cervical cancer risk prediction in HIV-positive
Nigerian women.
Int J Cancer. 2025 Jun 9. doi: 10.1002/ijc.35502. PubMedAbstract available
April 2025
KALJOUW S, Jansen EEL, Schevenhoven VJC, de Kok IMCM, et al Should the age range of the Dutch hrHPV-based cervical cancer screening program
be broadened? A modelling study using cohort effects.
Int J Cancer. 2025 Apr 28. doi: 10.1002/ijc.35435. PubMedAbstract available
WEI Y, Gu L, Zhang Y, Yang Q, et al Efficacy of ALA-PDT in treating cervical low-grade squamous intraepithelial
lesions with high-risk HPV patients: A multicentre randomized controlled trial.
Int J Cancer. 2025 Apr 23. doi: 10.1002/ijc.35450. PubMedAbstract available
March 2025
ESLAHI M, Pizzato M, Heikkinen S, Martinsen JI, et al Socioeconomic position and risk of cervical cancer in the Nordic countries:
Results from the Nordic Occupational Cancer Study.
Int J Cancer. 2025 Mar 13. doi: 10.1002/ijc.35349. PubMedAbstract available
LI Z, Liu P, Yin A, Zhang B, et al Global landscape of cervical cancer incidence and mortality in 2022 and
predictions to 2030: The urgent need to address inequalities in cervical cancer.
Int J Cancer. 2025 Mar 3. doi: 10.1002/ijc.35369. PubMedAbstract available
CHEN Q, Yao X, Quan J, Jia X, et al The variations in the natural history of high-risk human papillomavirus
infections in Chinese healthy women aged 27-45 years compared with 18-26 years: A
prospective cohort study.
Int J Cancer. 2025;156:1043-1054. PubMedAbstract available
February 2025
KEBEDE HB, Mekuria S, Asegid N, Forslund O, et al High-risk human papillomavirus genotypes in previously unscreened
reproductive-age women in Ethiopia: A community-based cohort study.
Int J Cancer. 2025 Feb 14. doi: 10.1002/ijc.35335. PubMedAbstract available
HARPER DM, Paczos T, Ridder R, Huh WK, et al p16/ki-67 dual stain triage of individuals positive for HPV to detect cervical
precancerous lesions.
Int J Cancer. 2025 Feb 4. doi: 10.1002/ijc.35353. PubMedAbstract available
January 2025
DU L, Sun H, Tang L, Hao S, et al Cervical cancer incidence rates considering migration status in mainland China
using Bayesian model-Estimation based on 2016 cancer registry data.
Int J Cancer. 2025 Jan 23. doi: 10.1002/ijc.35346. PubMedAbstract available
ARROYO MUHR LS, Wang J, Hassan SS, Yilmaz E, et al Nationwide registry-based trial of risk-stratified cervical screening.
Int J Cancer. 2025;156:379-388. PubMedAbstract available
December 2024
VERHOEF L, Bleeker MCG, Polman N, Kroon KR, et al Colposcopy referrals and CIN3 detection after triage by host cell DNA methylation
and/or HPV genotyping in HPV positive women with low-grade cytology from a
population-based Dutch primary HPV screening trial.
Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35289. PubMedAbstract available
KEN-AMOAH S, Redl E, Domson BKS, Barrett JE, et al Performance of the WID-qEC test to detect uterine cancers in black women with
abnormal uterine bleeding: A prospective observational cohort study in Ghana.
Int J Cancer. 2024 Dec 10. doi: 10.1002/ijc.35260. PubMedAbstract available
November 2024
PEDERSEN BT, Sonne SB, Pedersen H, Andreasen EK, et al Participation and relative cost of attendance by direct-mail compared to opt-in
invitation strategy for HPV self-sampling targeting cervical screening
non-attenders: A large-scale, randomized, pragmatic study.
Int J Cancer. 2024 Nov 23. doi: 10.1002/ijc.35263. PubMedAbstract available
LIU H, Zou M, Shen M, Kamarulzaman A, et al HPV vaccination is highly effective and cost-effective for cervical cancer
prevention in women living with HIV in China: A cost-effectiveness analysis.
Int J Cancer. 2024 Nov 17. doi: 10.1002/ijc.35242. PubMedAbstract available
SCHAAFSMA M, Schuurman TN, Kootstra P, Issa D, et al Nationwide cohort study on the risk of high-grade cervical dysplasia and
carcinoma after conservative treatment or hysterectomy for adenocarcinoma in
situ.
Int J Cancer. 2024 Nov 4. doi: 10.1002/ijc.35237. PubMedAbstract available
LOUVANTO K, Verhoef L, Pimenoff V, Eriksson T, et al Low methylation marker levels among human papillomavirus-vaccinated women with
cervical high-grade squamous intraepithelial lesions.
Int J Cancer. 2024;155:1549-1557. PubMedAbstract available
October 2024
DESCAMPS P, Bosch Jose FX, Monsonego J, Neisingh O, et al Cervical cancer screening: Sharing best practices and addressing common
challenges in cervical cancer screening programs.
Int J Cancer. 2024 Oct 26. doi: 10.1002/ijc.35220. PubMed
LEHTINEN M, Elfstrom M, Vanska S, Dillner J, et al Elimination of cervical cancer by refined vaccination and screening.
Int J Cancer. 2024 Oct 25. doi: 10.1002/ijc.35228. PubMed
KOKEMULLER L, Ramachandran D, Schurmann P, Geffers R, et al Germline variants of homology-directed repair or mismatch repair genes in
cervical cancer.
Int J Cancer. 2024 Oct 23. doi: 10.1002/ijc.35221. PubMedAbstract available
MISHRA GA, Pimple SA, Anand KV, Kulkarni VY, et al Acceptability and validity of HPV self-sampling for cervical cancer screening
among women living in different ecological settings in India.
Int J Cancer. 2024 Oct 16. doi: 10.1002/ijc.35222. PubMedAbstract available
CUI M, Song L, Mao R, Lyu Y, et al Exposure to polycyclic aromatic hydrocarbons promotes the progression of
low-grade cervical intraepithelial neoplasia: A population-based cohort study in
China.
Int J Cancer. 2024;155:1162-1171. PubMedAbstract available
September 2024
CHEN J, Shi J, Cao Y, Li C, et al A new treatment approach of toripalimab in combination with concurrent
platinum-based chemoradiotherapy for locally advanced cervical cancer: A phase II
clinical trial.
Int J Cancer. 2024 Sep 28. doi: 10.1002/ijc.35206. PubMedAbstract available
DEBEAUDRAP P, Kabore FN, Setha L, Tegbe J, et al Performance of visual inspection, partial genotyping, and their combination for
the triage of women living with HIV who are screen positive for human
papillomavirus: Results from the AIMA-CC ANRS 12375 multicentric screening study.
Int J Cancer. 2024 Sep 25. doi: 10.1002/ijc.35190. PubMedAbstract available
OSTRBENK VALENCAK A, Kroon KR, Fabjan D, Mlakar J, et al Clinically validated HPV assays offer comparable long-term safety in primary
cervical cancer screening: A 9-year follow-up of a population-based screening
cohort.
Int J Cancer. 2024 Sep 24. doi: 10.1002/ijc.35200. PubMedAbstract available
FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al Effectiveness of self-sampling human papillomavirus test on precancer detection
and screening uptake in Japan: The ACCESS randomized controlled trial.
Int J Cancer. 2024;155:905-915. PubMedAbstract available
August 2024
SCHAAFSMA M, van den Helder R, Mom CH, Steenbergen RDM, et al Recurrent cervical cancer detection using DNA methylation markers in
self-collected samples from home.
Int J Cancer. 2024 Aug 22. doi: 10.1002/ijc.35143. PubMedAbstract available
July 2024
LYNGE E, Bennekou Schroll J, Andersen B, Balasubramaniam K, et al Cervical cancer incidence in Denmark: Disentangling determinants of time trend.
Int J Cancer. 2024 Jul 14. doi: 10.1002/ijc.35081. PubMedAbstract available
MORO F, Ciancia M, Zace D, Vagni M, et al Role of artificial intelligence applied to ultrasound in gynecology oncology: A
systematic review.
Int J Cancer. 2024 Jul 11. doi: 10.1002/ijc.35092. PubMedAbstract available
GILHAM C, Nedjai B, Scibior-Bentkowska D, Reuter C, et al Long-term prediction by DNA methylation of high-grade cervical intraepithelial
neoplasia: Results of the ARTISTIC cohort.
Int J Cancer. 2024;155:81-92. PubMedAbstract available
May 2024
LOBIN C, Orang'o EO, Were E, Muthoka K, et al Cost-effectiveness analysis of alternative screening strategies for the detection
of cervical cancer among women in rural areas of Western Kenya.
Int J Cancer. 2024 May 27. doi: 10.1002/ijc.35036. PubMedAbstract available
HANSEN BT, Nygard M, Castle PE, Burger EA, et al Sociodemographic characteristics associated with cervical cancer screening
participation by send-to-all and opt-in HPV self-sampling: Who benefits? Results
from a randomized controlled trial among long-term non-attending women in Norway.
Int J Cancer. 2024 May 15. doi: 10.1002/ijc.34989. PubMedAbstract available
April 2024
BUDUKH A, Dora T, Sancheti S, Singh V, et al Outcome of early detection approach in control of breast, cervical, and oral
cancer: Experience from a rural cancer center in India.
Int J Cancer. 2024 Apr 20. doi: 10.1002/ijc.34966. PubMedAbstract available
DOWNHAM L, Rol ML, Forestier M, Romero P, et al Field experience with the 8-HPV-type oncoprotein test for cervical cancer
screening among HPV-positive women living with and without HIV in LMICs.
Int J Cancer. 2024 Apr 11. doi: 10.1002/ijc.34953. PubMedAbstract available
March 2024
PORTNOY A, Pedersen K, Sy S, Trope A, et al Cost-effectiveness of primary human papillomavirus triage approaches among
vaccinated women in Norway: A model-based analysis.
Int J Cancer. 2024;154:1073-1081. PubMedAbstract available
LI N, Yi H, Sun W, Sundquist J, et al Revealing genes associated with cervical cancer in distinct immune cells: A
comprehensive Mendelian randomization analysis.
Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34911. PubMedAbstract available
STERPETTI AV, Gabriele R, Iannone I, Sapienza P, et al Reduced adherence to cervical cancer screening. The importance of information and
education for women with low education and low-income.
Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34907. PubMed
OLTHOF EMG, Aitken CA, Siebers AG, van Kemenade FJ, et al The impact of loss to follow-up in the Dutch organised HPV-based cervical cancer
screening programme.
Int J Cancer. 2024 Mar 4. doi: 10.1002/ijc.34902. PubMedAbstract available
February 2024
LINDQUIST S, Frederiksen K, Petersen LK, Kjaer SK, et al The risk of vaginal, vulvar and anal precancer and cancer according to high-risk
HPV status in cervical cytology samples.
Int J Cancer. 2024 Feb 28. doi: 10.1002/ijc.34896. PubMedAbstract available
WEN TM, Xu XQ, Zhao XL, Pan CH, et al Efficacy and immunogenicity of AS04-HPV-16/18 vaccine in females with existing
cervical HR-HPV infection at first vaccination: A pooled analysis of four large
clinical trials worldwide.
Int J Cancer. 2024 Feb 17. doi: 10.1002/ijc.34882. PubMedAbstract available
January 2024
AMBOREE TL, Damgacioglu H, Sonawane K, Adsul P, et al Recent trends in cervical cancer incidence, stage at diagnosis, and mortality
according to county-level income in the United States, 2000-2019.
Int J Cancer. 2024 Jan 25. doi: 10.1002/ijc.34860. PubMedAbstract available
LEHTINEN M, Bruni L, Elfstrom M, Gray P, et al Scientific approaches toward improving cervical cancer elimination strategies.
Int J Cancer. 2024 Jan 9. doi: 10.1002/ijc.34839. PubMedAbstract available
EL-ZEIN M, Cheishvili D, Szyf M, Franco EL, et al Validation of novel DNA methylation markers in cervical precancer and cancer.
Int J Cancer. 2024;154:104-113. PubMedAbstract available
December 2023
Harald zur Hausen 1936-2023.
Int J Cancer. 2023;153:1937-1939. PubMed
DICK S, Heideman DAM, Mom CH, Meijer CJLM, et al Methylation testing for the detection of recurrent cervical intraepithelial
neoplasia.
Int J Cancer. 2023;153:2011-2018. PubMedAbstract available
November 2023
TULSIDAS S, Fontes F, Monteiro K, Mussa M, et al Cervical cancer in Mozambique: Clinical characteristics, treatment and survival
of incident cases admitted to the Oncology Service of Maputo Central Hospital in
2016-2018.
Int J Cancer. 2023 Nov 14. doi: 10.1002/ijc.34779. PubMedAbstract available
BONI SP, Tenet V, Horo A, Heideman DAM, et al High-risk human papillomavirus distribution according to human immunodeficiency
virus status among women with cervical cancer in Abidjan, Cote d'Ivoire, 2018 to
2020.
Int J Cancer. 2023 Nov 9. doi: 10.1002/ijc.34774. PubMedAbstract available
October 2023
Correction to "Randomized multicenter phase II trial of prophylactic irradiation
of para-aortic lymph nodes in advanced cervical cancer according to tumor
hypoxia: Korean Radiation Oncology Group (KROG 07-01) study".
Int J Cancer. 2023 Oct 31. doi: 10.1002/ijc.34775. PubMed
COCUZZA CE, Dhillon SK, Martinelli M, Giubbi C, et al Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative
Typing assay using the VALGENT framework.
Int J Cancer. 2023 Oct 19. doi: 10.1002/ijc.34754. PubMedAbstract available
September 2023
INTURRISI F, de Sanjose S, Desai KT, Dagnall C, et al A rapid HPV typing assay to support global cervical cancer screening and
risk-based management: A cross-sectional study.
Int J Cancer. 2023 Sep 29. doi: 10.1002/ijc.34698. PubMedAbstract available
MUNGO C, Osongo CO, Ambaka J, Omoto J, et al Efficacy of thermal ablation for treatment of biopsy-confirmed high-grade
cervical precancer among women living with HIV in Kenya.
Int J Cancer. 2023 Sep 15. doi: 10.1002/ijc.34737. PubMedAbstract available
WANG J, Edvardsson H, Strander B, Andrae B, et al Long-term follow-up of cervical cancer incidence after normal cytological
findings.
Int J Cancer. 2023 Sep 11. doi: 10.1002/ijc.34723. PubMedAbstract available
DHOKOTERA TG, Muchengeti M, Davidovic M, Rohner E, et al Gynaecologic and breast cancers in women living with HIV in South Africa: A
record linkage study.
Int J Cancer. 2023 Sep 8. doi: 10.1002/ijc.34712. PubMedAbstract available
FERNANDEZ VILLALOBOS NV, Ruffieux Y, Haas AD, Chinogurei C, et al Cervical precancer and cancer incidence among insured women with and without HIV
in South Africa.
Int J Cancer. 2023 Sep 2. doi: 10.1002/ijc.34707. PubMedAbstract available
August 2023
WHITE C, Reynolds S, Murphy K, Keegan H, et al Performance of the HPV E6/E7 mRNA Aptima HPV assay combined with partial
genotyping compared with the HPV DNA Cobas 4800 HPV test for use in primary
screening: Results from the CERVIVA HPV primary screening study in Ireland.
Int J Cancer. 2023 Aug 26. doi: 10.1002/ijc.34685. PubMedAbstract available
July 2023
REBOLJ M, Sargent A, Njor SH, Cuschieri K, et al Widening the offer of human papillomavirus self-sampling to all women eligible
for cervical screening: Make haste slowly.
Int J Cancer. 2023;153:8-19. PubMedAbstract available
June 2023
QI L, Wang M, Jia Y, Wang Y, et al Impact of the COVID-19 pandemic on the hospital attendance of patients with
primary cervical cancer in Heilongjiang, China.
Int J Cancer. 2023 Jun 1. doi: 10.1002/ijc.34617. PubMedAbstract available
May 2023
PESOLA F, Rebolj M, Sasieni P Managing an extension of screening intervals: Avoiding boom and bust in health
care workloads.
Int J Cancer. 2023;152:2061-2068. PubMedAbstract available
April 2023
TISLER A, Nygard M, Kivite-Urtane A, Berza N, et al Comment on "The European response to the WHO call to eliminate cervical cancer as
a public health problem".
Int J Cancer. 2023 Apr 19. doi: 10.1002/ijc.34540. PubMed
March 2023
CUZICK J, Adcock R, Kinney W, Castle PE, et al Impact of HPV testing in Opportunistic Cervical Screening: Support for Primary
HPV Screening in the United States.
Int J Cancer. 2023 Mar 22. doi: 10.1002/ijc.34519. PubMedAbstract available
WEVER BMM, van den Helder R, van Splunter AP, van Gent MDJM, et al DNA methylation testing for endometrial cancer detection in urine, cervicovaginal
self-samples, and cervical scrapes.
Int J Cancer. 2023 Mar 13. doi: 10.1002/ijc.34504. PubMedAbstract available
DONG L, Nygard M, Stoer NC, Klungsoyr O, et al Real-World Effectiveness of Hpv Vaccination Against Cervical Neoplasia Among
Birth Cohorts Ineligible for Routine Vaccination.
Int J Cancer. 2023 Mar 3. doi: 10.1002/ijc.34489. PubMedAbstract available
February 2023
HERZOG C, Vavourakis CD, Barrett JE, Karbon G, et al HPV-induced host epigenetic reprogramming is lost upon progression to high-grade
cervical intraepithelial neoplasia.
Int J Cancer. 2023 Feb 21. doi: 10.1002/ijc.34477. PubMedAbstract available
December 2022
BARRETT JE, Jones A, Evans I, Herzog C, et al The WID-EC test for the detection and risk prediction of endometrial cancer.
Int J Cancer. 2022 Dec 19. doi: 10.1002/ijc.34406. PubMedAbstract available